Literature DB >> 2083994

An evaluation of lot quality assurance sampling to monitor and improve immunization coverage.

C F Lanata1, G Stroh, R E Black, H Gonzales.   

Abstract

Quality assurance sampling techniques with small samples offer a method of monitoring performance of health services in small health areas, and of identifying areas with poor performance in which remedial actions need to be targetted. Lot Quality Assurance Sampling methods were used to assess the coverage resulting from three immunization campaigns in rural and urban areas in the mountains of Peru. Application of these methods in 12 health areas with populations of 538 to 15 780 by Ministry of Health personnel proved feasible and could be used to identify areas with poorer vaccination coverage. Further discussion about possible reasons for poor coverage led to corrective actions in these health areas and an improvement in overall coverage from 78% to 88% in a three-month period. These quality assurance methods are a useful supervisory tool to improve health programme performance.

Mesh:

Year:  1990        PMID: 2083994     DOI: 10.1093/ije/19.4.1086

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  13 in total

1.  [Acceptance of lot sampling: its applicability to the evaluation of the primary care services portfolio].

Authors:  J López-Picazo Ferrer
Journal:  Aten Primaria       Date:  2001-05-15       Impact factor: 1.137

2.  Rapid assessment of Schistosoma mansoni: the validity, applicability and cost-effectiveness of the Lot Quality Assurance Sampling method in Uganda.

Authors:  Simon Brooker; Narcis B Kabatereine; Mark Myatt; J Russell Stothard; Alan Fenwick
Journal:  Trop Med Int Health       Date:  2005-07       Impact factor: 2.622

Review 3.  Trachoma survey methods: a literature review.

Authors:  Jeremiah Ngondi; Mark Reacher; Fiona Matthews; Carol Brayne; Paul Emerson
Journal:  Bull World Health Organ       Date:  2009-02       Impact factor: 9.408

4.  Intervene before leaving: clustered lot quality assurance sampling to monitor vaccination coverage at health district level before the end of a yellow fever and measles vaccination campaign in Sierra Leone in 2009.

Authors:  Lorenzo Pezzoli; Ishata Conteh; Wogba Kamara; Marta Gacic-Dobo; Olivier Ronveaux; William A Perea; Rosamund F Lewis
Journal:  BMC Public Health       Date:  2012-06-07       Impact factor: 3.295

5.  Whom and where are we not vaccinating? Coverage after the introduction of a new conjugate vaccine against group A meningococcus in Niger in 2010.

Authors:  Sung Hye Kim; Lorenzo Pezzoli; Harouna Yacouba; Tiekoura Coulibaly; Mamoudou H Djingarey; William A Perea; Thomas F Wierzba
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

Review 6.  The use of schools for malaria surveillance and programme evaluation in Africa.

Authors:  Simon Brooker; Jan H Kolaczinski; Carol W Gitonga; Abdisalan M Noor; Robert W Snow
Journal:  Malar J       Date:  2009-10-19       Impact factor: 2.979

Review 7.  Factors associated with missed vaccination during mass immunization campaigns.

Authors:  William M Weiss; Peter J Winch; Gilbert Burnham
Journal:  J Health Popul Nutr       Date:  2009-06       Impact factor: 2.000

8.  Performance of the lot quality assurance sampling method compared to surveillance for identifying inadequately-performing areas in Matlab, Bangladesh.

Authors:  Abbas Bhuiya; S M A Hanifi; Nikhil Roy; P Kim Streatfield
Journal:  J Health Popul Nutr       Date:  2007-03       Impact factor: 2.000

9.  PCR and Mosquito dissection as tools to monitor filarial infection levels following mass treatment.

Authors:  David S Goodman; Jean-Nicolas Orelus; Jacquelin M Roberts; Patrick J Lammie; Thomas G Streit
Journal:  Filaria J       Date:  2003-07-07

Review 10.  Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010-2014.

Authors:  Mamoudou H Djingarey; Fabien V K Diomandé; Rodrigue Barry; Denis Kandolo; Florence Shirehwa; Clement Lingani; Ryan T Novak; Carol Tevi-Benissan; William Perea; Marie-Pierre Preziosi; F Marc LaForce
Journal:  Clin Infect Dis       Date:  2015-11-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.